Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - CAPRICOR THERAPEUTICS, INC. | v403079_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - CAPRICOR THERAPEUTICS, INC. | v403079_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - CAPRICOR THERAPEUTICS, INC. | v403079_ex21-1.htm |
| EX-32.2 - EXHIBIT 32.2 - CAPRICOR THERAPEUTICS, INC. | v403079_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - CAPRICOR THERAPEUTICS, INC. | v403079_ex32-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - CAPRICOR THERAPEUTICS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - CAPRICOR THERAPEUTICS, INC. | v403079_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements of Capricor Therapeutics, Inc. on Form S-8 (File Nos. 333-152283, 333-175727, and 333-194317) of our report dated March 6, 2015, relating to the consolidated financial statements, appearing in this Annual Report on Form 10-K.
/s/ Rose, Snyder & Jacobs LLP
Rose, Snyder & Jacobs LLP
Encino, California
March 16, 2015